EFFECTS OF KETOCONAZOLE ON THE POLYMORPHIC 4-HYDROXYLATIONS OF S-MEPHENYTOIN AND DEBRISOQUINE

被引：24

作者：

ATIBA, JO

BLASCHKE, TF

WILKINSON, GR

机构：

[1] VANDERBILT UNIV,DEPT PHARMACOL,NASHVILLE,TN 37232

[2] STANFORD UNIV,MED CTR,SCH MED,DIV CLIN PHARMACOL,STANFORD,CA 94305

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1989年 / 28卷 / 02期

关键词：

D O I：

10.1111/j.1365-2125.1989.tb05409.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：161 / 165

页数：5

共 20 条

[1] SPARTEINE OXIDATION IS PRACTICALLY ABOLISHED IN QUINIDINE-TREATED PATIENTS [J].

BRINN, R ;

BROSEN, K ;

GRAM, LF ;

HAGHFELT, T ;

OTTON, SV .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 (02) :194-197

[2] EXTENSIVE METABOLIZERS OF DEBRISOQUINE BECOME POOR METABOLIZERS DURING QUINIDINE TREATMENT [J].

BROSEN, K ;

GRAM, LF ;

HAGHFELT, T ;

BERTILSSON, L .

PHARMACOLOGY & TOXICOLOGY, 1987, 60 (04) :312-314

[3] CLINICAL PHARMACOKINETICS OF KETOCONAZOLE [J].

DANESHMEND, TK ;

WARNOCK, DW .

CLINICAL PHARMACOKINETICS, 1988, 14 (01) :13-34

[4]

DISTLERATH LM, 1985, J BIOL CHEM, V260, P9057

[5]

HALL SD, 1987, J PHARMACOL EXP THER, V240, P216

[6] DEBRISOQUINE HYDROXYLATION CAPACITY - PROBLEMS OF ASSESSMENT IN 2 POPULATIONS [J].

INABA, T ;

OTTON, SV ;

KALOW, W .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (02) :218-223

[7] QUINIDINE - POTENT INHIBITION OF SPARTEINE AND DEBRISOQUINE OXIDATION INVIVO [J].

INABA, T ;

TYNDALE, RE ;

MAHON, WA .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 (02) :199-200

[8] POLYMORPHIC DRUG OXIDATION - PHARMACOKINETIC BASIS AND COMPARISON OF EXPERIMENTAL INDEXES [J].

JACKSON, PR ;

TUCKER, GT ;

LENNARD, MS ;

WOODS, HF .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 (05) :541-550

[9] POLYMORPHIC METABOLISM OF MEPHENYTOIN IN MAN - PHARMACOKINETIC INTERACTION WITH A CO-REGULATED SUBSTRATE, MEPHOBARBITAL [J].

JACQZ, E ;

HALL, SD ;

BRANCH, RA ;

WILKINSON, GR .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (06) :646-653

[10]

KNODELL RG, 1988, J PHARMACOL EXP THER, V245, P845

← 1 2 →